Queen’s research finds cancer drug can treat blindness
A drug designed to fight cancer is as effective a treatment for a cause of blindness as a tailor-made product more than 10 times the cost, new research has found.
A two year trial at Queen’s University Belfast has discovered that anti-cancer drug Avastin is as good a treatment for neovascular or wet age-related macular degeneration (wet AMD) than the most commonly used drug for the condition - Lucentis.
Wet AMD is a common cause of sight loss in older people with at least 23,000 older people diagnosed with the condition in the UK each year.
Without treatment two thirds of people with this condition will experience severe loss of sight within two years of being diagnosed.